Itron (NASDAQ:ITRI) Rating Increased to Buy at Johnson Rice

Johnson Rice upgraded shares of Itron (NASDAQ:ITRI) from an accumulate rating to a buy rating in a report issued on Monday morning, Marketbeat Ratings reports. The firm currently has $130.00 target price on the scientific and technical instruments company’s stock.

ITRI has been the subject of a number of other research reports. Weiss Ratings reiterated a “buy (b-)” rating on shares of Itron in a research note on Monday, December 29th. Baird R W cut Itron from a “strong-buy” rating to a “hold” rating in a report on Friday, October 31st. Oppenheimer set a $145.00 price objective on Itron and gave the stock an “outperform” rating in a research note on Friday, October 31st. Robert W. Baird restated a “neutral” rating and issued a $118.00 target price (down from $137.00) on shares of Itron in a research note on Friday, October 31st. Finally, JPMorgan Chase & Co. lifted their price target on Itron from $145.00 to $155.00 and gave the company an “overweight” rating in a report on Thursday, October 16th. Nine research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $138.10.

Itron Stock Up 2.4%

Shares of NASDAQ:ITRI opened at $96.73 on Monday. Itron has a 52 week low of $90.11 and a 52 week high of $142.00. The company has a debt-to-equity ratio of 0.46, a quick ratio of 1.91 and a current ratio of 2.17. The company’s fifty day moving average is $99.72 and its 200-day moving average is $118.07. The company has a market capitalization of $4.43 billion, a PE ratio of 17.40, a P/E/G ratio of 0.53 and a beta of 1.49.

Itron (NASDAQ:ITRI) last announced its earnings results on Thursday, October 30th. The scientific and technical instruments company reported $1.54 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.48 by $0.06. Itron had a net margin of 10.69% and a return on equity of 17.82%. The business had revenue of $581.63 million during the quarter, compared to analysts’ expectations of $578.49 million. During the same quarter last year, the company posted $1.84 EPS. The firm’s revenue for the quarter was down 5.5% on a year-over-year basis. Itron has set its FY 2025 guidance at 6.840-6.940 EPS and its Q4 2025 guidance at 2.150-2.250 EPS. Equities research analysts predict that Itron will post 5.33 earnings per share for the current fiscal year.

Insider Buying and Selling at Itron

In related news, SVP John F. Marcolini sold 553 shares of the firm’s stock in a transaction dated Monday, November 24th. The stock was sold at an average price of $96.51, for a total value of $53,370.03. Following the transaction, the senior vice president owned 13,843 shares in the company, valued at $1,335,987.93. This trade represents a 3.84% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Joan S. Hooper sold 948 shares of the business’s stock in a transaction dated Monday, November 24th. The stock was sold at an average price of $96.51, for a total value of $91,491.48. Following the sale, the chief financial officer directly owned 87,446 shares of the company’s stock, valued at $8,439,413.46. This represents a 1.07% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 2,971 shares of company stock valued at $286,731 over the last ninety days. Company insiders own 1.51% of the company’s stock.

Hedge Funds Weigh In On Itron

Hedge funds and other institutional investors have recently bought and sold shares of the business. Mirabella Financial Services LLP bought a new stake in shares of Itron during the 3rd quarter valued at $226,000. Tudor Investment Corp ET AL grew its stake in shares of Itron by 47.2% during the third quarter. Tudor Investment Corp ET AL now owns 274,644 shares of the scientific and technical instruments company’s stock worth $34,210,000 after purchasing an additional 88,029 shares during the period. Swiss Life Asset Management Ltd increased its holdings in Itron by 0.8% in the third quarter. Swiss Life Asset Management Ltd now owns 111,772 shares of the scientific and technical instruments company’s stock valued at $13,922,000 after purchasing an additional 874 shares during the last quarter. CIBC Private Wealth Group LLC lifted its stake in Itron by 7.2% in the third quarter. CIBC Private Wealth Group LLC now owns 4,251 shares of the scientific and technical instruments company’s stock valued at $530,000 after buying an additional 287 shares during the period. Finally, CIBC Bancorp USA Inc. acquired a new position in Itron in the third quarter valued at about $604,000. 96.19% of the stock is owned by institutional investors.

About Itron

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.